Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lipohydroxy acid is a derivative of salicylic acid (a beta hydroxy acid) used primarily in skincare products for its exfoliating and acne-treating properties. Its unique structure—a long-chain fatty acyl group—makes it more lipophilic than salicylic acid, allowing it to dissolve in oils and penetrate the sebum-rich pilosebaceous unit. This results in slow, controlled penetration and cell-by-cell exfoliation that is gentler on the skin compared to traditional BHAs. Lipohydroxy acid promotes skin renewal by stimulating glycosaminoglycans, collagen, and elastin production; it also has comedolytic (pore-unclogging), anti-inflammatory, antibacterial effects and can reduce hyperpigmentation. It is commonly found in over-the-counter creams, cleansers, toners and spot treatments for acne-prone or aging skin[1][2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lipohydroxy acid.